On the other hand, systemically administration with an agonist which could selectively upregulate TRIM67 enzyme activity or enhance its interaction with IκBα may provide protective effects against cerebral ischemia–reperfusion injury. The gene discussed is TRIM67; the disease is brain ischemia.